30 October 2009 11:15 [Source: ICIS news]
(Adds comment from analyst in paragraph eight)
LONDON (ICIS news)--DSM is searching for a new partner in China after its joint venture with North China Pharmaceutical Group Corporation (NCPC) was put on hold, the Dutch material science and global life sciences company said on Friday.
Plans to establish a nutrition and anti-infectives joint venture, which the company had been working towards since 2004, had been suspended following a change in ownership of NCPC, the company said in statement.
“The implementation of these contracts has been delayed and possibly cannot be effectuated within a reasonable timeframe,” it added.
As a result, DSM was looking for an alternative partner and exploring other opportunities for growth in ?xml:namespace>
“DSM is very well positioned in
The company has 14 manufacturing sites in
Xu Liehai, an analyst from Beijing-based brokerage firm China Merchants, said it was likely that the contracts between the two parties would be reworked rather that cancelled, adding that it is difficult to find suitable partnership companies in
Judith Wang also contributed to this story
To discuss issues facing the chemical industry visit ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|